More
    Guided Solutions - Connecting Talent With Innovation/div>

    iCardio.ai wins second FDA 510(k) clearance for CardioVision

    iCardio.ai announces FDA 510(k) Clearance for CardioVision. This is the company’s second FDA clearance. CardioVision can automatically detect aortic stenosis, a disease affecting 1.5M Americans with a one-way prognosis, whose only intervention is a valve...

    iCardio.ai wins second FDA 510(k) clearance for CardioVision

    iCardio.ai announces FDA 510(k) Clearance for CardioVision. This is the company’s second FDA clearance. CardioVision can automatically detect aortic stenosis, a disease affecting 1.5M Americans...

    JenaValve reports positive Trilogy heart valve data for aortic regurgitation

    JenaValve announced new results from an expanded patient cohort supporting the use of its Trilogy transcatheter heart valve (THV) system. Results from the ALIGN-AR pivotal...

    Cordance Medical raises $8M seed for focused ultrasound used in brain treatment

    Cordance Medical announced that it raised more than $8 million in an oversubscribed seed financing round. Sonder Capital led the round, which included participation from...

    Solventum bolsters wound care portfolio with $850m Acera Surgical acquisition

    Solventum has acquired US-based Acera Surgical in a deal worth up to $850m, positioning the company to progress in the synthetic tissue matrices technology...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    JenaValve reports positive Trilogy heart valve data for aortic regurgitation

    JenaValve announced new results from an expanded patient cohort supporting the use of its Trilogy transcatheter heart valve (THV) system. Results from the ALIGN-AR pivotal...

    Vexev robotic ultrasound study meets endpoints

    Vexev and U.S. Renal Care announced successful results from the CANSCAN trial of the VxWave robotic ultrasound imaging system. Sydney, Australia-based Vexev develops the...

    Hyperion completes first-in-human study of Ivy robotic vascular access platform

    Hyperion Surgical announced today that it completed the world’s first robotic-assisted intravenous (IV) catheterisation using its Ivy platform. Ivy integrates advanced imaging, AI and robotic...

    AtriCure treats first patient in the BoxX-NoAF clinical trial

    AtriCure, a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced...

    Innovation

    Regulatory Approvals

    iCardio.ai wins second FDA 510(k) clearance for CardioVision

    iCardio.ai announces FDA 510(k) Clearance for CardioVision. This is the company’s second FDA clearance. CardioVision can automatically detect aortic stenosis, a disease affecting 1.5M Americans...

    JenaValve reports positive Trilogy heart valve data for aortic regurgitation

    JenaValve announced new results from an expanded patient cohort supporting the use of its Trilogy transcatheter heart valve (THV) system. Results from the ALIGN-AR pivotal...

    Cordance Medical raises $8M seed for focused ultrasound used in brain treatment

    Cordance Medical announced that it raised more than $8 million in an oversubscribed seed financing round. Sonder Capital led the round, which included participation from...

    Solventum bolsters wound care portfolio with $850m Acera Surgical acquisition

    Solventum has acquired US-based Acera Surgical in a deal worth up to $850m, positioning the company to progress in the synthetic tissue matrices technology...

    M&A

    Archives

    Latest articles